Who Paid My Doc
Xlif
Device Spine/Spine Surgery
PDI 00887517804112
General payments
$12,134,646
Research payments
$3,427,681
Through program year 2025, $12,134,646 in general payments and $3,427,681 in research payments were reported against Xlif (Spine/Spine Surgery).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
10 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $1,343,872 | 2,450 |
| 2025 | Research | $668,200 | 211 |
| 2024 | General | $1,194,912 | 1,962 |
| 2024 | Research | $809,348 | 190 |
| 2023 | General | $1,832,166 | 3,841 |
| 2023 | Research | $994,784 | 215 |
| 2022 | General | $3,437,253 | 4,371 |
| 2022 | Research | $580,034 | 152 |
| 2021 | General | $4,326,443 | 4,182 |
| 2021 | Research | $375,315 | 141 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.
The top 5 of 34 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 50 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
16,806 general · 909 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.